Open Access

[Erratum] Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro

  • Authors:
    • Masayoshi Yamaguchi
    • Tomiyasu Murata
  • View Affiliations

  • Published online on: December 12, 2017     https://doi.org/10.3892/mmr.2017.8276
  • Pages: 3432-3432
  • Copyright: © Yamaguchi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

February-2018
Volume 17 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yamaguchi M and Yamaguchi M: [Erratum] Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro. Mol Med Rep 17: 3432-3432, 2018
APA
Yamaguchi, M., & Yamaguchi, M. (2018). [Erratum] Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro. Molecular Medicine Reports, 17, 3432-3432. https://doi.org/10.3892/mmr.2017.8276
MLA
Yamaguchi, M., Murata, T."[Erratum] Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro". Molecular Medicine Reports 17.2 (2018): 3432-3432.
Chicago
Yamaguchi, M., Murata, T."[Erratum] Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro". Molecular Medicine Reports 17, no. 2 (2018): 3432-3432. https://doi.org/10.3892/mmr.2017.8276